| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.903 | 0.004 | 0.903 | Anticonvulsant | |||
| 0.776 | 0.002 | 0.776 | GABA receptor antagonist | |||
| 0.77 | 0.002 | 0.77 | GABA A receptor antagonist | |||
| 0.762 | 0.002 | 0.762 | Benzodiazepine agonist | 0.068 0.054 CID_62966 | ||
| 0.71 | 0.003 | 0.71 | GABA receptor agonist | |||
| 0.618 | 0.004 | 0.618 | Anesthetic general | 0.491 0.008 CID_62966 | ||
| 0.611 | 0.006 | 0.611 | GABA C receptor rho-3 antagonist | |||
| 0.567 | 0.007 | 0.567 | Psychostimulant | 0.409 0.021 CID_62966 | ||
| 0.426 | 0.016 | 0.426 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.303 | 0.004 | 0.303 | Potassium channel activator | |||
| 0.282 | 0.007 | 0.282 | GABA C receptor rho-2 antagonist | |||
| 0.293 | 0.036 | 0.293 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.294 | 0.038 | 0.294 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.23 | 0.002 | 0.23 | Benzodiazepine receptor peripheral-type antagonist | 0.097 0.004 CID_62966 | ||
| 0.212 | 0.005 | 0.212 | Cyclin B3 inhibitor | |||
| 0.353 | 0.147 | 0.353 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.213 | 0.01 | 0.213 | Interleukin 8 antagonist | |||
| 0.223 | 0.022 | 0.223 | Death-associated protein kinase 2 inhibitor | |||
| 0.241 | 0.056 | 0.244 | RNA-directed DNA polymerase inhibitor | 0.244 0.053 CID_62966 | CID_62966 | |
| 0.246 | 0.062 | 0.246 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.192 | 0.016 | 0.192 | Protein kinase C gamma inhibitor | |||
| 0.175 | 0.015 | 0.175 | Protein kinase C zeta inhibitor | |||
| 0.176 | 0.019 | 0.176 | GABA C receptor antagonist | |||
| 0.15 | 0.003 | 0.15 | Benzodiazepine antagonist | |||
| 0.303 | 0.161 | 0.377 | 5 Hydroxytryptamine release inhibitor | 0.377 0.094 CID_62966 | CID_62966 | |
| 0.175 | 0.035 | 0.175 | Glutamate receptor antagonist | |||
| 0.154 | 0.02 | 0.154 | GABA C receptor rho-1 antagonist | |||
| 0.223 | 0.091 | 0.223 | Aryl hydrocarbon receptor agonist | |||
| 0.15 | 0.025 | 0.351 | Beta glucuronidase inhibitor | 0.351 0.005 CID_62966 | CID_62966 | |
| 0.13 | 0.013 | 0.163 | Glycine receptor antagonist | 0.163 0.005 CID_62966 | CID_62966 | |
| 0.142 | 0.027 | 0.142 | NMDA receptor antagonist | |||
| 0.118 | 0.009 | 0.118 | NMDA receptor glycine site agonist | |||
| 0.131 | 0.029 | 0.131 | Electrolyte absorption antagonist | |||
| 0.1 | 0.008 | 0.1 | Cholecystokinin antagonist | |||
| 0.193 | 0.102 | 0.198 | Nitric-oxide synthase stimulant | 0.198 0.092 CID_62966 | CID_62966 | |
| 0.154 | 0.065 | 0.268 | Lipid peroxidase inhibitor | 0.268 0.024 CID_62966 | CID_62966 | |
| 0.102 | 0.015 | 0.102 | GABA B receptor agonist | |||
| 0.092 | 0.008 | 0.092 | Kainate receptor antagonist | |||
| 0.101 | 0.019 | 0.101 | NMDA receptor agonist | |||
| 0.146 | 0.073 | 0.146 | MAP kinase 3 inhibitor | |||
| 0.131 | 0.058 | 0.131 | MAP kinase 12 inhibitor | |||
| 0.144 | 0.075 | 0.144 | MAP kinase kinase 4 inhibitor | |||
| 0.081 | 0.014 | 0.081 | Cyclin B2 inhibitor | |||
| 0.088 | 0.021 | 0.088 | Plasminogen activator inhibitor | |||
| 0.154 | 0.088 | 0.154 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.119 | 0.056 | 0.119 | MAP kinase 13 inhibitor | |||
| 0.155 | 0.093 | 0.277 | ATPase inhibitor | 0.277 0.009 CID_62966 | CID_62966 | |
| 0.085 | 0.024 | 0.085 | Protein kinase C beta inhibitor | |||
| 0.081 | 0.021 | 0.081 | Cyclin B1 inhibitor | |||
| 0.083 | 0.022 | 0.083 | Protein kinase C eta inhibitor | 0.049 0.045 CID_62966 | ||
| 0.075 | 0.019 | 0.075 | AMPA receptor antagonist | |||
| 0.074 | 0.018 | 0.074 | Cyclin B inhibitor | |||
| 0.176 | 0.122 | 0.176 | ErbB-1 antagonist | |||
| 0.134 | 0.08 | 0.134 | Protein kinase C nu inhibitor | |||
| 0.058 | 0.005 | 0.058 | NMDA receptor glycine site antagonist | |||
| 0.134 | 0.081 | 0.242 | Cell wall synthesis inhibitor | 0.242 0.017 CID_62966 | CID_62966 | |
| 0.135 | 0.085 | 0.135 | Pregnane X receptor agonist | |||
| 0.24 | 0.192 | 0.24 | Analgesic | |||
| 0.154 | 0.108 | 0.154 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.18 | 0.134 | 0.18 | DNA damaging | 0.161 0.157 CID_62966 | ||
| 0.063 | 0.018 | 0.063 | NMDA receptor subunit 3B antagonist | |||
| 0.098 | 0.056 | 0.143 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.143 0.029 CID_62966 | CID_62966 | |
| 0.057 | 0.017 | 0.057 | Purinergic P2X4 antagonist | |||
| 0.149 | 0.109 | 0.149 | Catenin beta inhibitor | |||
| 0.097 | 0.059 | 0.097 | Protein kinase C mu inhibitor | |||
| 0.052 | 0.015 | 0.052 | Kainate receptor 2 antagonist | |||
| 0.072 | 0.034 | 0.072 | MDM2 inhibitor | |||
| 0.177 | 0.142 | 0.338 | Interleukin agonist | 0.338 0.033 CID_62966 | CID_62966 | |
| 0.045 | 0.01 | 0.045 | Cyclin E2 inhibitor | |||
| 0.173 | 0.139 | 0.456 | Antioxidant | 0.456 0.026 CID_62966 | CID_62966 | |
| 0.037 | 0.005 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.013 CID_62966 | ||
| 0.044 | 0.012 | 0.044 | Cholecystokinin B antagonist | |||
| 0.138 | 0.109 | 0.164 | Interleukin 6 antagonist | 0.164 0.07 CID_62966 | CID_62966 | |
| 0.054 | 0.028 | 0.162 | Phosphorylase inhibitor | 0.162 0.006 CID_62966 | CID_62966 | |
| 0.148 | 0.123 | 0.148 | MAP kinase kinase 2 inhibitor | |||
| 0.086 | 0.063 | 0.163 | NADH dehydrogenase inhibitor | 0.163 0.015 CID_62966 | CID_62966 | |
| 0.062 | 0.042 | 0.062 | Cannabinoid CB1 receptor antagonist | |||
| 0.043 | 0.023 | 0.043 | NMDA receptor subunit 3A antagonist | |||
| 0.045 | 0.026 | 0.045 | GABA B receptor antagonist | |||
| 0.09 | 0.072 | 0.09 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.034 | 0.019 | 0.034 | Estrogen-related receptor beta antagonist | |||
| 0.059 | 0.048 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.04 | 0.029 | 0.04 | Acid-sensing ion channel blocker | |||
| 0.034 | 0.024 | 0.034 | Factor XI inhibitor | |||
| 0.057 | 0.048 | 0.057 | Cyclin D1 inhibitor | |||
| 0.061 | 0.053 | 0.061 | Kallikrein 7 inhibitor | |||
| 0.14 | 0.132 | 0.14 | Succinate dehydrogenase inhibitor | |||
| 0.044 | 0.037 | 0.044 | Benzodiazepine inverse agonist | |||
| 0.127 | 0.124 | 0.127 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.022 | 0.02 | 0.022 | Kainate receptor 4 antagonist | |||
| 0.062 | 0.061 | 0.062 | Prostaglandin-E synthase inhibitor | |||
| 0.105 | 0.107 | 0.12 | Alkaline phosphatase inhibitor | 0.12 0.085 CID_62966 | CID_62966 | |
| 0.023 | 0.035 | 0.095 | Trypsin I inhibitor | 0.095 0.007 CID_62966 | CID_62966 | |
| 0.054 | 0.069 | 0.106 | Trypsin inhibitor | 0.106 0.015 CID_62966 | CID_62966 | |
| 0.145 | 0.162 | 0.28 | Cyclic AMP phosphodiesterase inhibitor | 0.28 0.05 CID_62966 | CID_62966 | |
| 0.072 | 0.106 | 0.173 | UDP-glucose 4-epimerase inhibitor | 0.173 0.023 CID_62966 | CID_62966 | |
| 0.102 | 0.141 | 0.125 | Mannose-6-phosphate isomerase inhibitor | 0.125 0.092 CID_62966 | CID_62966 | |
| 0.016 | 0.056 | 0.115 | Factor X inhibitor | 0.115 0.009 CID_62966 | CID_62966 | |
| 0.019 | 0.068 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.008 CID_62966 | CID_62966 | |
| 0.073 | 0.122 | 0.087 | Glutamate release inhibitor | 0.087 0.069 CID_62966 | CID_62966 | |
| 0.063 | 0.139 | 0.112 | DNA intercalator | 0.112 0.063 CID_62966 | CID_62966 | |
| 0.099 | 0.175 | 0.228 | Hemostatic | 0.228 0.025 CID_62966 | CID_62966 | |
| 0.218 | 0.295 | 0.293 | Caspase 9 stimulant | 0.293 0.202 CID_62966 | CID_62966 | |
| 0.051 | 0.139 | 0.192 | Topoisomerase I inhibitor | 0.192 0.028 CID_62966 | CID_62966 | |
| 0.143 | 0.235 | 0.388 | Cholesterol antagonist | 0.388 0.052 CID_62966 | CID_62966 | |
| 0.089 | 0.182 | 0.165 | DNA repair enzyme inhibitor | 0.165 0.02 CID_62966 | CID_62966 | |
| 0.038 | 0.144 | 0.112 | Topoisomerase II alpha inhibitor | 0.112 0.033 CID_62966 | CID_62966 | |
| 0.07 | 0.177 | 0.097 | Photosensitizer | 0.097 0.095 CID_62966 | CID_62966 | |
| 0.133 | 0.249 | 0.358 | Peptidyltransferase inhibitor | 0.358 0.011 CID_62966 | CID_62966 | |
| 0.011 | 0.13 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 CID_62966 | CID_62966 | |
| 0.13 | 0.252 | 0.229 | DNA synthesis inhibitor | 0.229 0.084 CID_62966 | CID_62966 | |
| 0.028 | 0.156 | 0.083 | Heparanase inhibitor | 0.083 0.006 CID_62966 | CID_62966 | |
| 0.061 | 0.195 | 0.107 | Alpha-N-acetylglucosaminidase inhibitor | 0.107 0.092 CID_62966 | CID_62966 | |
| 0.008 | 0.148 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 CID_62966 | CID_62966 | |
| 0.145 | 0.298 | 0.374 | Histamine release inhibitor | 0.374 0.089 CID_62966 | CID_62966 | |
| 0.02 | 0.174 | 0.111 | Antineoplastic antibiotic | 0.111 0.042 CID_62966 | CID_62966 | |
| 0.047 | 0.208 | 0.081 | Triose-phosphate isomerase inhibitor | 0.081 0.075 CID_62966 | CID_62966 | |
| 0.05 | 0.218 | 0.165 | AMP-activated protein kinase stimulant | 0.165 0.02 CID_62966 | CID_62966 | |
| 0.034 | 0.202 | 0.058 | Adenine nucleotide translocase inhibitor | 0.058 0.032 CID_62966 | CID_62966 | |
| 0.017 | 0.21 | 0.079 | Protein 50S ribosomal subunit inhibitor | 0.079 0.02 CID_62966 | CID_62966 | |
| 0.072 | 0.301 | 0.346 | Free radical scavenger | 0.346 0.04 CID_62966 | CID_62966 | |
| 0.041 | 0.277 | 0.159 | Amylase inhibitor | 0.159 0.06 CID_62966 | CID_62966 | |
| 0.032 | 0.275 | 0.095 | ATPase (Vacuolar H+) inhibitor | 0.095 0.046 CID_62966 | CID_62966 | |
| 0.072 | 0.328 | 0.131 | Interferon gamma antagonist | 0.131 0.108 CID_62966 | CID_62966 | |
| 0.059 | 0.318 | 0.141 | Hexokinase inhibitor | 0.141 0.09 CID_62966 | CID_62966 | |
| 0.113 | 0.381 | 0.316 | Apoptosis antagonist | 0.316 0.075 CID_62966 | CID_62966 | |
| 0.109 | 0.377 | 0.489 | Antibacterial | 0.489 0.044 CID_62966 | CID_62966 | |
| 0.093 | 0.365 | 0.136 | CC chemokine 6 receptor antagonist | 0.136 0.049 CID_62966 | CID_62966 | |
| 0.007 | 0.296 | 0.026 | Protein 30S ribosomal subunit inhibitor | 0.026 0.015 CID_62966 | CID_62966 | |
| 0.033 | 0.321 | 0.056 | Lipocortins synthesis agonist | 0.056 0.045 CID_62966 | CID_62966 | |
| 0.062 | 0.355 | 0.144 | Non-steroidal antiinflammatory agent | 0.144 0.124 CID_62966 | CID_62966 | |
| 0.086 | 0.382 | 0.433 | Antithrombotic | 0.433 0.042 CID_62966 | CID_62966 | |
| 0.112 | 0.425 | 0.358 | Interleukin 2 agonist | 0.358 0.042 CID_62966 | CID_62966 | |
| 0.102 | 0.421 | 0.21 | Caspase 3 stimulant | 0.21 0.155 CID_62966 | CID_62966 | |
| 0.057 | 0.377 | 0.176 | NOS3 expression enhancer | 0.176 0.052 CID_62966 | CID_62966 | |
| 0.042 | 0.364 | 0.133 | Cyclooxygenase 3 inhibitor | 0.133 0.064 CID_62966 | CID_62966 | |
| 0.023 | 0.37 | 0.131 | Topoisomerase II inhibitor | 0.131 0.059 CID_62966 | CID_62966 | |
| 0.035 | 0.387 | 0.133 | Anticoagulant | 0.133 0.096 CID_62966 | CID_62966 | |
| 0.04 | 0.393 | 0.31 | Immunostimulant | 0.31 0.076 CID_62966 | CID_62966 | |
| 0.019 | 0.374 | 0.063 | Factor IXa inhibitor | 0.063 0.025 CID_62966 | CID_62966 | |
| 0.015 | 0.427 | 0.056 | Glucose-6-phosphate translocase inhibitor | 0.056 0.028 CID_62966 | CID_62966 | |
| 0.081 | 0.529 | 0.362 | Apoptosis agonist | 0.362 0.132 CID_62966 | CID_62966 | |
| 0.035 | 0.504 | 0.156 | Vasodilator | 0.156 0.148 CID_62966 | CID_62966 | |
| 0.017 | 0.506 | 0.222 | Acetylcholinesterase inhibitor | 0.222 0.027 CID_62966 | CID_62966 | |
| 0.026 | 0.528 | 0.12 | Toll-Like receptor 4 antagonist | 0.12 0.044 CID_62966 | CID_62966 | |
| 0.011 | 0.52 | 0.058 | Antibiotic Aminoglycoside-like | 0.058 0.009 CID_62966 | CID_62966 | |
| 0.036 | 0.558 | 0.239 | Transcription factor NF kappa B inhibitor | 0.239 0.135 CID_62966 | CID_62966 | |
| 0.049 | 0.584 | 0.249 | Immunomodulator | 0.249 0.116 CID_62966 | CID_62966 | |
| 0.032 | 0.626 | 0.318 | Immunosuppressant | 0.318 0.104 CID_62966 | CID_62966 | |
| 0.005 | 0.641 | 0.241 | Selectin antagonist | 0.241 0.009 CID_62966 | CID_62966 | |
| 0.017 | 0.664 | 0.2 | Nitric oxide antagonist | 0.2 0.067 CID_62966 | CID_62966 | |
| 0.017 | 0.679 | 0.137 | Insulin secretagoues | 0.137 0.089 CID_62966 | CID_62966 | |
| 0.012 | 0.682 | 0.183 | Cholinergic | 0.183 0.055 CID_62966 | CID_62966 | |
| 0.041 | 0.72 | 0.455 | Antiinflammatory | 0.455 0.108 CID_62966 | CID_62966 | |
| 0.013 | 0.704 | 0.43 | Angiogenesis stimulant | 0.43 0.017 CID_62966 | CID_62966 | |
| 0.027 | 0.737 | 0.276 | Hepatoprotectant | 0.276 0.037 CID_62966 | CID_62966 | |
| 0.024 | 0.746 | 0.091 | Transcription factor NF kappa B stimulant | 0.091 0.049 CID_62966 | CID_62966 | |
| 0.016 | 0.779 | 0.21 | Platelet adhesion inhibitor | 0.21 0.066 CID_62966 | CID_62966 | |
| 0.019 | 0.804 | 0.333 | Hypoglycemic | 0.333 0.042 CID_62966 | CID_62966 | |
| 0.009 | 0.818 | 0.098 | Cell adhesion inhibitor | 0.098 0.094 CID_62966 | CID_62966 | |
| 0.008 | 0.825 | 0.162 | Thrombolytic | 0.162 0.073 CID_62966 | CID_62966 | |
| 0.005 | 0.929 | 0.368 | Cyclophilin D inhibitor | 0.368 0.11 CID_62966 | CID_62966 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |